Angiotensin II type 1a-deficient bone marrow-derived dendritic cells produce higher levels of monocyte chemoattractant protein 1.
Karen A
KA
Nahmod
Jorge R
JR
Geffner
Thomas
T
Walther
D000804:Angiotensin II / Q000633:toxicity; D000818:Animals; D001853:Bone Marrow / Q000276:immunology* / Q000473:pathology; D018932:Chemokine CCL2 / Q000096:biosynthesis*; D003713:Dendritic Cells / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D004195:Disease Models, Animal; D005921:Glomerulonephritis / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D006973:Hypertension / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D007111:Immunity, Cellular; D051379:Mice; D018345:Mice, Knockout; D044140:Receptor, Angiotensin, Type 1 / Q000172:deficiency*
D018932:Chemokine CCL2; D044140:Receptor, Angiotensin, Type 1; D000804:Angiotensin II